Valneva continues ongoing discussions with the european commission for inactivated covid-19 vaccine candidate

Saint- herblain (france), july 1 , 2021 – following a media article published yesterday, valneva se, (nasdaq: valn; euronext paris: vla), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, indicated today it continues ongoing discussions with the european commission regarding vla2001, valneva's inactivated covid-19 vaccine candidate.
VALN Ratings Summary
VALN Quant Ranking